Skip to content

Efficacy check of skin care product

To evaluate the in-vivo safety and efficacy of the skin care formulation in terms of reduction in acne reduction in pore size, reduction in skin sebum content & improvement in skin brightness on healthy human subjects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060574
Enrollment
36
Registered
2023-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Jamun Active Acne Control: Approx. 0.5-1 gms quantity of product to be used to wash the face. Product to be applied twice in a day for period of 14 days. Control Intervention1: Nil: NA

Sponsors

SATIYA NUTRACEUTICALS PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Skin is healthy on the studied anatomic unit 2)Having mild to moderate acne 3)Having mixed oily or oily skin on the face. 4)Having visible pores

Exclusion criteria

Exclusion criteria: 1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form. 2)Taking part in another study liable to interfere with this study. 3)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 5)Having a progressive asthma (either under treatment or last fit in the last 2 years) 6)Being epileptic 7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8)Having cutaneous hypersensitivity 9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex 10) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 12)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit 13)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted). 14)Having applied hair oil during the entire duration of the study

Design outcomes

Primary

MeasureTime frame
Reduction in acne reduction in pore size, reduction in skin sebum content & improvement in skin brightnessTimepoint: Baseline, Day 3, Day 7, Day 14

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026